Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4174

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Cyclobenzaprine HCI Extended-Release 30 mg Capsules with a quantity of 30 capsules. The prescription medication is manufactured by Teva in Frazer, PA. The text includes important information like the NDC number, storage directions, and the manufacturer's details. It also reminds the user to keep the medication out of the reach of children and points to a package insert for directions on usage.*
FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
FDA Label Image

Image (Image 2)

Image (Image 2)
FDA Label Image

Image (Image 3)

Image (Image 3)
FDA Label Image

Image (Image 4)

Image (Image 4)
FDA Label Image

Image (Image 5)

Image (Image 5)
FDA Label Image

Image (Image 6)

Image (Image 6)
FDA Label Image

Image (Image 7)

Image (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.